![Bryant Lim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 107 134 $ in data 30/09/2026
Bryant D.
Lim is currently Director at Life Sciences Pennsylvania since 2019.
Mr. Lim is also CFO, Secretary, and Chief Legal Officer at Prelude Therapeutics, Inc. starting in 2024.
Formerly, Mr. Lim was Chief Business Officer, SVP, and General Counsel at Aceragen, Inc. from 2022 to 2023.
Mr. Lim was Secretary, Senior VP, and General Counsel at Idera Pharmaceuticals, Inc. from 2018 to 2022.
Mr. Lim was Chief Compliance Officer and Vice President at Incyte Corp.
from 2014 to 2018.
Mr. Lim worked as Assistant Counsel at Merck & Co., Inc. and as Associate General Counsel at Viropharma, Inc. Education includes undergraduate studies at Rochester Christian University and graduate studies at Villanova University School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/04/2026 | 27.400 ( 0,04% ) | 107 134 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Direttore Finanziario/CFO | 08/04/2024 |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Direttore/Membro del Consiglio | 01/05/2019 |
| Società | Posizione | Fine |
|---|---|---|
| ACERAGEN, INC. | Consigliere Generale | 17/02/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Consigliere Generale | 01/10/2022 |
| INCYTE CORPORATION | Responsabile della Conformità | 01/09/2018 |
Viropharma, Inc. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Villanova University School of Law
 Villanova University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Viropharma, Inc. | |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
